Zealand Nabs Novo Nordisk To Save Zegalogue Launch
Boosts Turnaround At Troubled Danish Firm
US approval for its hypoglycemia injection Zegalogue last year has not been converted into commercial success. Zealand will be hoping that having diabetes giant Novo Nordisk onboard will put that right.
